Supply Chain Ecosystem Analysis now part of DBMR Reports
Market Size in USD Billion
| 2023 –2030 | |
|
|
USD 1.20 Billion |
| USD 2.06 Billion | |
| % | |
|
Global Automated Blood Collection Market, By Product (Needles and Syringes, Blood Collection Tubes, Blood Bags, Lancets, Others), Type (Plastic Blood Collection Tubes, Glass Blood Collection Tubes, Stainless Steel Blood Collection Tubes, Ceramic Blood Collection Tubes), Application (Diagnostics, Treatment, Therapeutics), End User (Hospitals and Pathology Laboratories, Diagnostic Centers, Blood Banks, Others) – Industry Trends and Forecast to 2030.
The growing number of hospital surgical procedures is driving the global automated blood collection market. Patients undergoing chemotherapy, dialysis, organ and tissue transplantation, and complex surgeries benefit from blood collection products. The increasing prevalence of chronic and lifestyle diseases as a result of sedentary lifestyles has necessitated greater adherence to regular health check-ups. This has increased the demand for automated blood collection as the primary method of disease diagnosis.
Data Bridge Market Research analyses that the automated blood collection market which was USD 1.2 billion in 2022, is expected to reach USD 2.06 billion by 2030, at a CAGR of 7.0% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product (Needles and Syringes, Blood Collection Tubes, Blood Bags, Lancets, Others), Type (Plastic Blood Collection Tubes, Glass Blood Collection Tubes, Stainless Steel Blood Collection Tubes, Ceramic Blood Collection Tubes), Application (Diagnostics, Treatment, Therapeutics), End User (Hospitals and Pathology Laboratories, Diagnostic Centers, Blood Banks, Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
BD (U.S.), Terumo BCT Inc. (U.S.), Fresenius KABI AG (Germany), Grifols S.A. (Spain), Nipro Medical Corporation (U.S.), Greiner AG (Austria), Quest Diagnostics Incorporated (U.S.), Mitra Industries Private Limited (India), SARSTEDT AG & Co. KG (Germany), CML Biotech (India), Macopharma (France), Neomedic Limited (U.S.), Haemonetics Corporation (U.S.), ICU Medical, Inc. (U.S.), SB-KAWASUMI LABORATORIES, INC. (Japan), Retractable Technologies Inc. (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Automated blood collection is the process of drawing blood from a vein using an automated machine. This procedure is frequently used for patients who require frequent blood tests or who have difficulty having their blood drawn manually. Automated blood collection can also be used to collect larger volumes of blood for research purposes.
Drivers
The spread of infectious diseases, hospital-acquired infections, and the discomfort caused by frequent needle sticks have all been reduced as a result of advancements in a new class of blood collection and processing technology and software. During blood collection and processing procedures, medical experts and their assistants use a variety of technologies and consumables to comprehensively analyse and diagnose infection-causing organisms such as bacteria, viruses, and other pathogens before separating distinct blood components for treating patients who are deficient in a specific blood component. As a result of the increase in chronic diseases and surgical procedures, there has been a surge in demand for pathogen-free blood and its components.
High demand for blood donations and components is expected to drive market growth due to the emergence of liquid biopsy tests, an increase in accidents and trauma cases, and disease incidence.
Furthermore, an increase in demand for apheresis, an increase in the incidence of infectious diseases, the presence of a large number of diagnostic laboratories and hospitals, and an increase in the prevalence of people with blood disorders have all contributed to a rise in demand for the automated blood collection market from 2023 to 2030.
Opportunities
Technological advancements such as portable blood collection, Hemosep 3-D printed blood collection devices, blood collection tubes design, blood management robotics, RFID technology, and microfluidic blood collection devices are expected to impact the automated blood collection market, because of their distinct features. For instance, Rutgers University researchers developed Venibot, a "venipuncture robot" that can draw blood and run tests on its own. This robot uses a combination of near-infrared and ultrasound imaging to locate blood arteries before injecting the patient, and then creates a 3D model of the vessels.
Restraints/Challenges
The high costs of automated blood collection devices may impede the growth of the automated blood collection market during the forecast period, whereas the complexities of storage and shipping, as well as a lack of skilled professionals, are the major challenges to the growth of the automated blood collection market.
Rise in dependence, contamination and adequate sampling will obstruct the market's growth rate. Uneven spreading of the blood drop on a porous substrate due to the differences in the haematocrit volume of blood of different patients, formation of clot or blot during the spotting process, heterogeneous distribution of analyses of blood on the porous paper due to the thin layer chromatography effect are some of the factors which lead to contamination and hamper the growth of the market.
This automated blood collection market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the automated blood collection market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
It is anticipated that the COVID-19 epidemic, a previously unheard-of worldwide public health threat, will considerably affect the automated blood collection market. In general, both hospital and independent labs evaluate each test to determine whether to suggest laboratory haematologists' consultations for tests with a higher risk profile or to not offer procedures that could not be performed safely. In the early stages of the pandemic, this had a detrimental impact on the market and decreased the use of blood collection devices.
The automated blood collection market is segmented on the basis of product, type, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
Type
Application
End User
The automated blood collection market is analyzed and market size insights and trends are provided by country, product, type, application and end user as referenced above.
The countries covered in the automated blood collection market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the automated blood collection market due to the increase in R&D activities and the presence of leading clinical diagnostics companies in the region.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 owing to the rising disposable income and increasing prevalence of sepsis and HAI in this particular region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The automated blood collection market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for automated blood collection market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the automated blood collection market. The data is available for historic period 2011-2021.
The automated blood collection market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to automated blood collection market.
Some of the major players operating in the automated blood collection market are:
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.
SKU-
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL AUTOMATED BLOOD COLLECTION MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 ARRIVING AT THE GLOBAL AUTOMATED BLOOD COLLECTION MARKET
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 MARKET GUIDE
2.2.4 COMPANY POSITIONING GRID
2.2.5 COMAPANY MARKET SHARE ANALYSIS
2.2.6 MULTIVARIATE MODELLING
2.2.7 TOP TO BOTTOM ANALYSIS
2.2.8 STANDARDS OF MEASUREMENT
2.2.9 VENDOR SHARE ANALYSIS
2.2.10 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.11 DATA POINTS FROM KEY SECONDARY DATABASES
2.3 GLOBAL AUTOMATED BLOOD COLLECTION MARKET: RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
6 REGULATORY SCENARIO
7 GLOBAL AUTOMATED BLOOD COLLECTION MARKET, BY PRODUCT
7.1 OVERVIEW
7.2 AUTOMATED BLOOD COLLECTION DEVICES
7.2.1 PORTABLE
7.2.2 STANDALONE
7.2.3 HAND-HELD
7.3 CONSUMABLES
7.3.1 AUTOMATED BLOOD SAMPLING COLLECTION TUBES
7.3.1.1. PLASTIC BLOOD COLLECTION TUBES
7.3.1.2. GLASS BLOOD COLLECTION TUBES
7.3.1.3. OTHERS
7.3.2 NEEDLES AND SYRINGES
7.3.3 BLOOD BAGS
7.3.4 LANCETS
7.3.5 OTHERS
8 GLOBAL AUTOMATED BLOOD COLLECTION MARKET, BY COLLECTION TYPE
8.1 OVERVIEW
8.2 ARTERIAL SAMPLING
8.3 VENIPUNCTURE SAMPLING
8.4 FINGERSTICK SAMPLING
9 GLOBAL AUTOMATED BLOOD COLLECTION MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 DIAGNOSTICS
9.2.1 AUTOMATED BLOOD COLLECTION DEVICES
9.2.1.1. PORTABLE
9.2.1.2. STANDALONE
9.2.1.3. HAND-HELD
9.2.2 CONSUMABLES
9.2.2.1. AUTOMATED BLOOD SAMPLING COLLECTION TUBES
9.2.2.1.1. PLASTIC BLOOD COLLECTION TUBES
9.2.2.1.2. GLASS BLOOD COLLECTION TUBES
9.2.2.1.3. OTHERS
9.2.2.2. NEEDLES AND SYRINGES
9.2.2.3. BLOOD BAGS
9.2.2.4. LANCETS
9.2.2.5. OTHERS
9.3 TREATMENT
9.3.1 AUTOMATED BLOOD COLLECTION DEVICES
9.3.1.1. PORTABLE
9.3.1.2. STANDALONE
9.3.1.3. HAND-HELD
9.3.2 CONSUMABLES
9.3.2.1. AUTOMATED BLOOD SAMPLING COLLECTION TUBES
9.3.2.1.1. PLASTIC BLOOD COLLECTION TUBES
9.3.2.1.2. GLASS BLOOD COLLECTION TUBES
9.3.2.1.3. OTHERS
9.3.2.2. NEEDLES AND SYRINGES
9.3.2.3. BLOOD BAGS
9.3.2.4. LANCETS
9.3.2.5. OTHERS
10 GLOBAL AUTOMATED BLOOD COLLECTION MARKET, BY END USER
10.1 OVERVIEW
10.2 HOSPITALS
10.2.1 AUTOMATED BLOOD COLLECTION DEVICES
10.2.2 CONSUMABLES
10.3 PATHOLOGY LABORATORIES
10.3.1 AUTOMATED BLOOD COLLECTION DEVICES
10.3.2 CONSUMABLES
10.4 DIAGNOSTIC CENTERS
10.4.1 AUTOMATED BLOOD COLLECTION DEVICES
10.4.2 CONSUMABLES
10.5 BLOOD BANKS
10.5.1 AUTOMATED BLOOD COLLECTION DEVICES
10.5.2 CONSUMABLES
10.6 RESEARCH & ACADEMIC LABORATORIES
10.6.1 AUTOMATED BLOOD COLLECTION DEVICES
10.6.2 CONSUMABLES
10.7 OTHERS
11 GLOBAL AUTOMATED BLOOD COLLECTION MARKET, BY DISTRIBUTION CHANNEL
11.1 OVERVIEW
11.2 DIRECT TENDER
11.3 RETAIL SALES
11.4 ONLINE SALES
11.5 OTHERS
12 GLOBAL AUTOMATED BLOOD COLLECTION MARKET, BY GEOGRAPHY
GLOBAL AUTOMATED BLOOD COLLECTION MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
12.1 NORTH AMERICA
12.1.1 U.S.
12.1.2 CANADA
12.1.3 MEXICO
12.2 EUROPE
12.2.1 GERMANY
12.2.2 U.K.
12.2.3 ITALY
12.2.4 FRANCE
12.2.5 SPAIN
12.2.6 SWITZERLAND
12.2.7 NETHERLANDS
12.2.8 BELGIUM
12.2.9 RUSSIA
12.2.10 TURKEY
12.2.11 REST OF EUROPE
12.3 ASIA-PACIFIC
12.3.1 JAPAN
12.3.2 CHINA
12.3.3 SOUTH KOREA
12.3.4 INDIA
12.3.5 AUSTRALIA
12.3.6 SINGAPORE
12.3.7 THAILAND
12.3.8 INDONESIA
12.3.9 MALAYSIA
12.3.10 PHILIPPINES
12.3.11 REST OF ASIA-PACIFIC
12.4 SOUTH AMERICA
12.4.1 BRAZIL
12.4.2 ARGETINA
12.4.3 REST OF SOUTH AMERICA
12.5 MIDDLE EAST AND AFRICA
12.5.1 SOUTH AFRICA
12.5.2 EGYPT
12.5.3 ISRAEL
12.5.4 UAE
12.5.5 SAUDI ARABIA
12.5.6 REST OF MIDDLE EAST AND AMERICA
13 GLOBAL AUTOMATED BLOOD COLLECTION MARKET, COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: GLOBAL
13.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
13.3 COMPANY SHARE ANALYSIS: EUROPE
13.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
13.5 MERGERS & ACQUISITIONS
13.6 NEW PRODUCT DEVELOPMENT & APPROVALS
13.7 EXPANSIONS & PARTNERSHIP
13.8 REGULATORY CHANGES
14 COMPANY PROFILE
14.1 TEMPUS 600
14.1.1 COMPANY OVERVIEW
14.1.2 REVENUE ANALYSIS
14.1.3 GEOGRAPHIC PRESENCE
14.1.4 PRODUCT PORTFOLIO
14.1.5 RECENT DEVELOPMENTS
14.2 INSTECH LABORATORIES, INC.
14.2.1 COMPANY OVERVIEW
14.2.2 GEOGRAPHIC PRESENCE
14.2.3 PRODUCT PORTFOLIO
14.2.4 RECENT DEVELOPMENTS
14.3 NIPRO
14.3.1 COMPANY OVERVIEW
14.3.2 REVENUE ANALYSIS
14.3.3 GEOGRAPHIC PRESENCE
14.3.4 PRODUCT PORTFOLIO
14.3.5 RECENT DEVELOPMENTS
14.4 GRIFOLS
14.4.1 COMPANY OVERVIEW
14.4.2 REVENUE ANALYSIS
14.4.3 GEOGRAPHIC PRESENCE
14.4.4 PRODUCT PORTFOLIO
14.4.5 RECENT DEVELOPMENTS
14.5 TERUMO BCT, INC.
14.5.1 COMPANY OVERVIEW
14.5.2 GEOGRAPHIC PRESENCE
14.5.3 REVENUE ANALYSIS
14.5.4 PRODUCT PORTFOLIO
14.5.5 RECENT DEVELOPMENTS
14.6 KOCHIN INLAB EQUIPMENTS INDIA PVT LTD.
14.6.1 COMPANY OVERVIEW
14.6.2 GEOGRAPHIC PRESENCE
14.6.3 PRODUCT PORTFOLIO
14.6.4 RECENT DEVELOPMENTS
14.7 SELECTSCIENCE
14.7.1 COMPANY OVERVIEW
14.7.2 GEOGRAPHIC PRESENCE
14.7.3 PRODUCT PORTFOLIO
14.7.4 RECENT DEVELOPMENTS
14.8 VITESTRO
14.8.1 COMPANY OVERVIEW
14.8.2 REVENUE ANALYSIS
14.8.3 GEOGRAPHIC PRESENCE
14.8.4 PRODUCT PORTFOLIO
14.8.5 RECENT DEVELOPMENTS
14.9 IMMUCOR
14.9.1 COMPANY OVERVIEW
14.9.2 GEOGRAPHIC PRESENCE
14.9.3 PRODUCT PORTFOLIO
14.9.4 RECENT DEVELOPMENTS
14.1 BASINC
14.10.1 COMPANY OVERVIEW
14.10.2 GEOGRAPHIC PRESENCE
14.10.3 PRODUCT PORTFOLIO
14.10.4 RECENT DEVELOPMENTS
14.11 HEMAXIS
14.11.1 COMPANY OVERVIEW
14.11.2 REVENUE ANALYSIS
14.11.3 GEOGRAPHIC PRESENCE
14.11.4 PRODUCT PORTFOLIO
14.11.5 RECENT DEVELOPMENTS
14.12 BECTON, DICKINSON AND COMPANY
14.12.1 COMPANY OVERVIEW
14.12.2 REVENUE ANALYSIS
14.12.3 GEOGRAPHIC PRESENCE
14.12.4 PRODUCT PORTFOLIO
14.12.5 RECENT DEVELOPMENTS
14.13 MEDWRENCH, LLC.
14.13.1 COMPANY OVERVIEW
14.13.2 REVENUE ANALYSIS
14.13.3 GEOGRAPHIC PRESENCE
14.13.4 PRODUCT PORTFOLIO
14.13.5 RECENT DEVELOPMENTS
14.14 GREINER BIO-ONE INTERNATIONAL GMBH
14.14.1 COMPANY OVERVIEW
14.14.2 REVENUE ANALYSIS
14.14.3 GEOGRAPHIC PRESENCE
14.14.4 PRODUCT PORTFOLIO
14.14.5 RECENT DEVELOPMENTS
14.15 RETRACTABLE TECHNOLOGIES, INC.
14.15.1 COMPANY OVERVIEW
14.15.2 REVENUE ANALYSIS
14.15.3 GEOGRAPHIC PRESENCE
14.15.4 PRODUCT PORTFOLIO
14.15.5 RECENT DEVELOPMENTS
14.16 HAEMONETICS CORPORATION
14.16.1 COMPANY OVERVIEW
14.16.2 GEOGRAPHIC PRESENCE
14.16.3 PRODUCT PORTFOLIO
14.16.4 RECENT DEVELOPMENTS
14.17 CML BIOTECH
14.17.1 COMPANY OVERVIEW
14.17.2 REVENUE ANALYSIS
14.17.3 GEOGRAPHIC PRESENCE
14.17.4 PRODUCT PORTFOLIO
14.17.5 RECENT DEVELOPMENTS
14.18 ICUMEDICAL HUMAN CONNECTIONS
14.18.1 COMPANY OVERVIEW
14.18.2 GEOGRAPHIC PRESENCE
14.18.3 PRODUCT PORTFOLIO
14.18.4 RECENT DEVELOPMENTS
14.19 FRESENIUS KABI AG
14.19.1 COMPANY OVERVIEW
14.19.2 GEOGRAPHIC PRESENCE
14.19.3 PRODUCT PORTFOLIO
14.19.4 RECENT DEVELOPMENTS
14.2 BECKMAN COULTER, INC.
14.20.1 COMPANY OVERVIEW
14.20.2 GEOGRAPHIC PRESENCE
14.20.3 PRODUCT PORTFOLIO
14.20.4 RECENT DEVELOPMENTS
15 RELATED REPORTS
16 CONCLUSION
17 QUESTIONNAIRE
18 ABOUT DATA BRIDGE MARKET RESEARCH
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.